User contributions for CHoppe
7 November 2024
- 12:2712:27, 7 November 2024 diff hist +104 Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia No edit summary
- 11:1511:15, 7 November 2024 diff hist +457 Akiba et al. (2018): Vitamin D Supplementation and Survival of Patients with Non–small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
5 November 2024
- 12:2512:25, 5 November 2024 diff hist −15 Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer No edit summary current
- 12:2512:25, 5 November 2024 diff hist +80 Keshavarzi et al. (2019): The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer No edit summary
- 11:4211:42, 5 November 2024 diff hist −15 Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial No edit summary
- 11:3611:36, 5 November 2024 diff hist +82 Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial No edit summary
- 11:2411:24, 5 November 2024 diff hist +1 Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial No edit summary
- 11:2111:21, 5 November 2024 diff hist +140 Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial No edit summary
- 10:5610:56, 5 November 2024 diff hist +9 Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial No edit summary
- 10:3510:35, 5 November 2024 diff hist +88 Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial No edit summary
- 10:2510:25, 5 November 2024 diff hist −43 Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial No edit summary
31 October 2024
- 12:2012:20, 31 October 2024 diff hist −27 Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial No edit summary
- 12:2012:20, 31 October 2024 diff hist +71 Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial No edit summary
- 11:4211:42, 31 October 2024 diff hist −15 Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial No edit summary
- 11:4111:41, 31 October 2024 diff hist −1 Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial No edit summary
- 11:4111:41, 31 October 2024 diff hist −18 Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial No edit summary
- 11:4111:41, 31 October 2024 diff hist −5 Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial No edit summary
- 11:4011:40, 31 October 2024 diff hist +56 Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial No edit summary
- 09:1409:14, 31 October 2024 diff hist +48 Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
- 08:4908:49, 31 October 2024 diff hist +498 Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma No edit summary
- 08:2208:22, 31 October 2024 diff hist +2 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
- 08:2208:22, 31 October 2024 diff hist 0 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
- 08:2008:20, 31 October 2024 diff hist +5 Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) No edit summary
29 October 2024
- 11:5511:55, 29 October 2024 diff hist +5 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary current
- 11:4711:47, 29 October 2024 diff hist −14 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary
- 11:4711:47, 29 October 2024 diff hist +316 Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients No edit summary
- 10:5010:50, 29 October 2024 diff hist +2 Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial No edit summary
- 10:4810:48, 29 October 2024 diff hist 0 Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial No edit summary
- 10:4810:48, 29 October 2024 diff hist +276 Rastelli et al. (2011): Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial No edit summary
- 09:4809:48, 29 October 2024 diff hist −1 Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer No edit summary
- 09:4809:48, 29 October 2024 diff hist +9 Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer No edit summary
- 09:3009:30, 29 October 2024 diff hist +382 Scher et al. (2011): Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer No edit summary
25 October 2024
- 10:1510:15, 25 October 2024 diff hist −9 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
- 10:1110:11, 25 October 2024 diff hist −9 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
- 10:0210:02, 25 October 2024 diff hist −9 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
- 09:5409:54, 25 October 2024 diff hist −47 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
- 09:4009:40, 25 October 2024 diff hist −44 Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study No edit summary
24 October 2024
- 08:4608:46, 24 October 2024 diff hist −3 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
- 08:4408:44, 24 October 2024 diff hist +284 Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial No edit summary
22 October 2024
- 09:0809:08, 22 October 2024 diff hist +65 Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT No edit summary
- 08:4708:47, 22 October 2024 diff hist +70 Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study No edit summary
- 08:4008:40, 22 October 2024 diff hist +249 Jacot et al. (2016): Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study No edit summary
19 October 2024
- 10:5610:56, 19 October 2024 diff hist +132 Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators No edit summary
- 10:4510:45, 19 October 2024 diff hist +264 Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators No edit summary
17 October 2024
- 16:0216:02, 17 October 2024 diff hist 0 Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators No edit summary
11 October 2024
- 13:0613:06, 11 October 2024 diff hist +182 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
- 13:0313:03, 11 October 2024 diff hist +2 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
- 12:5512:55, 11 October 2024 diff hist −144 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
- 12:5512:55, 11 October 2024 diff hist +1 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary
- 11:5911:59, 11 October 2024 diff hist +744 Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer No edit summary